MGMT promoter methylation in Peruvian patients with glioblastoma

PURPOSE: O(6)-methylguanine–DNA methyltransferase (MGMT) promoter methylation predicts the outcome and response to alkylating chemotherapy in glioblastoma. The aim of this study is to evaluate the prevalence of MGMT methylation in Peruvian glioblastoma cases. PATIENTS AND METHODS: We evaluated retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Belmar-Lopez, Carolina, Castaneda, Carlos A, Castillo, Miluska, García-Corrochano, Pamela, Orrego, Enrique, Meléndez, Barbara, Casavilca, Sandro, Flores, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834313/
https://www.ncbi.nlm.nih.gov/pubmed/29515653
http://dx.doi.org/10.3332/ecancer.2018.812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834313/
https://www.ncbi.nlm.nih.gov/pubmed/29515653
http://dx.doi.org/10.3332/ecancer.2018.812

Ejemplares similares